98%
921
2 minutes
20
The increasing availability of large-scale brain imaging genetics studies enables more comprehensive exploration of the genetic underpinnings of brain functional organizations. However, fundamental analytical challenges arise when considering the complex network topology of brain functional connectivity, influenced by genetic contributions and sample relatedness, particularly in longitudinal studies. In this paper, we propose a novel method named Bayesian Longitudinal Network-Variant Regression (BLNR), which models the association between genetic variants and longitudinal brain functional connectivity. BLNR fills the gap in existing longitudinal genome-wide association studies that primarily focus on univariate or multivariate phenotypes. Our approach jointly models the biological architecture of brain functional connectivity and the associated genetic mixed-effect components within a Bayesian framework. By employing plausible prior settings and posterior inference, BLNR enables the identification of significant genetic signals and their associated brain sub-network components, providing robust inference. We demonstrate the superiority of our model through extensive simulations and apply it to the Adolescent Brain Cognitive Development (ABCD) study. This application highlights BLNR's ability to estimate the genetic effects on changes in brain network configurations during neurodevelopment, demonstrating its potential to extend to other similar problems involving sample relatedness and network-variate outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/sim.70069 | DOI Listing |
J Neural Transm (Vienna)
September 2025
Sárospatak College, Sztárai Institute, University of Tokaj, Eötvöst str. 7, Sárospatak, 3944, Hungary.
Generalized Anxiety Disorder (GAD) is characterized by excessive worry and physical symptoms of prolonged anxiety. Patients with subclinical GAD-states (sub-GAD) do not fulfill the diagnostic criteria of GAD, but they often show a disease burden similar to GAD, and the subclinical state may turn into a full syndrome. Neuroinflammation may contribute to changes in brain structures in sub-GAD, but direct evidence remains lacking.
View Article and Find Full Text PDFJ Neurooncol
September 2025
Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.
View Article and Find Full Text PDFBiochem Genet
September 2025
Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Kocamustafapasa, 34098, Istanbul, Turkey.
Glioblastoma is the most aggressive and malignant tumor of the central nervous system. Current treatment options, including surgical excision, radiotherapy, and chemotherapy, have Limited efficacy, with a median survival rate of approximately 15 months. To develop novel therapeutics, it is crucial to understand the underlying molecular mechanisms driving glioblastoma.
View Article and Find Full Text PDFMol Psychiatry
September 2025
Nencki Institute of Experimental Biology of Polish Academy of Sciences, 3 Pasteur St., Warsaw, 02-093, Poland.
Alcohol use disorder (AUD) is characterized by pathological motivation to consume alcohol and cognitive inflexibility, leading to excessive alcohol seeking and use. In this study, we investigated the molecular correlates of impaired extinction of alcohol seeking during forced abstinence using a mouse model of AUD in the automated IntelliCage social system. This model distinguished AUD-prone and AUD-resistant animals based on the presence of ≥2 or <2 criteria of AUD, respectively.
View Article and Find Full Text PDFNat Aging
September 2025
Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.
Clinical Alzheimer's disease is currently characterized by cerebral β-amyloidosis associated with cognitive impairment. However, most cases of Alzheimer's disease are associated with multiple neuropathologies at autopsy. The peripheral protein changes associated with these disease endophenotypes are poorly understood.
View Article and Find Full Text PDF